Por favor, use este identificador para citar o enlazar este ítem:
10.1016/j.jacc.2018.11.054
Twittear
Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Pascual Figal, Domingo A. | - |
dc.contributor.author | Bayes Genis, Antoni | - |
dc.contributor.author | Asensio Lopez, Maria del Carmen | - |
dc.contributor.author | Hernandez Vicente, Alvaro | - |
dc.contributor.author | Garrido Bravo, Iris | - |
dc.contributor.author | Pastor Peez, Francisco | - |
dc.contributor.author | Diez, Javier | - |
dc.contributor.author | Ibañez, Borja | - |
dc.contributor.author | Lax Pérez, Antonio Manuel | - |
dc.contributor.other | Facultades, Departamentos, Servicios y Escuelas::Departamentos de la UMU::Medicina | es |
dc.date.accessioned | 2024-01-24T09:28:08Z | - |
dc.date.available | 2024-01-24T09:28:08Z | - |
dc.date.issued | 2019-03 | - |
dc.identifier.citation | Journal of the American College of Cardiology (JACC) 2019 Mar 12;73(9):1016-1025.doi: 10.1016/j.jacc.2018.11.054. | es |
dc.identifier.issn | 1558-3597 | - |
dc.identifier.issn | 0735-1097 | - |
dc.identifier.uri | http://hdl.handle.net/10201/137660 | - |
dc.description | ©2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ This document is the Accepted version of a Published Work that appeared in final form in Journal of the American College of Cardiology (JACC). To access the final edited and published work see https://doi.org/10.1016/j.jacc.2018.11.054 | es |
dc.description.abstract | Background: Soluble ST2 (sST2), which is the soluble form of interleukin (IL)-1 receptor-like 1, identifies risk in acutely decompensated heart failure (ADHF). IL-1β is an inflammatory cytokine that has deleterious effects in myocardial remodeling and function. IL-1β inhibition has beneficial effects after acute myocardial infarction. However, the role of IL-1β in ADHF and its relationship to ST2 remain unclear. Objectives: This study sought to investigate the relationship between IL-1β and sST2, and the prognostic impact of such a relationship in patients with ADHF. Methods: This study examined 316 consecutive patients who were hospitalized with ADHF (72 ± 12 years of age, 57% male, and left ventricular ejection fraction 45 ± 17%). Blood samples were collected at presentation, and IL-1β and sST2 levels were measured. All-cause mortality was obtained for all patients at 1 year. Results: The IL-1β concentration at presentation was associated with prior HF hospitalizations, functional impairment, and higher N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T concentrations. IL-1β was higher in patients who died during the year after hospitalization (n = 52, 16.5%) (p = 0.005), and the optimal threshold was identified with levels over 49.1 pg/ml (hazard ratio: 2.5; 95% confidence interval: 1.43 to 4.49; p = 0.0014). Circulating IL-1β positively correlated with sST2 (ρ = 0.65; p < 0.001). Considering the prognostic thresholds of IL-1β (≥49.1 pg/ml) and sST2 (≥35.0 ng/ml) concentrations: all patients with low sST2 also presented with low IL-1β; among patients with high sST2, only those with also high IL-1β had a significantly higher risk of death (30% vs. 14%; hazard ratio: 2.52; 95% confidence interval: 1.40 to 4.56; p = 0.002). Conclusions: Circulating IL-1β concentrations are clinically meaningful in ADHF patients and interplay with the predictive ability of sST2. IL-1 axis-related inflammation signaling may represent a therapeutic target in ADHF. | es |
dc.format | application/pdf | es |
dc.format.extent | 10 | es |
dc.language | eng | es |
dc.relation | This work has been supported by grants PI14/01637 and PI17/01742 from “Instituto de Salud Carlos III,” Madrid, Spain, and grant PI14/19334 from “Fundación Séneca de Ciencia y Tecnología de la Región de Murcia,” Murcia, Spain. Dr. Pascual-Figal has received grant support from Roche Diagnostics; and has received educational fees from Novartis. | es |
dc.rights | info:eu-repo/semantics/openAccess | es |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.title | The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure | es |
dc.type | info:eu-repo/semantics/article | es |
dc.identifier.doi | 10.1016/j.jacc.2018.11.054 | - |
Aparece en las colecciones: | Artículos: Medicina |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure.pdf | 770,34 kB | Adobe PDF | Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons